Jundishapur Journal of Microbiology

Published by: Kowsar

Oncogenic Virus Infections in the General Population and End-stage Renal Disease Patients With Special Emphasis on Kaposi’s Sarcoma Associated Herpes Virus (KSHV) in Northeast of Iran

Sanaz Ahmadi Ghezeldasht 1 , Tahereh Hassannia 2 , Houshang Rafatpanah 3 , Reza Hekmat 4 , Narges Valizadeh 3 , Majid Ghayour Mobarhan 1 and Seyed Abdolrahim Rezaee 1 , 5 , *
Authors Information
1 Research Center for HIV/AIDS, HTLV and Viral Hepatitis, Iranian Academic Center for Education, Culture and Research (ACECR), Mashhad Branch, Mashhad, IR Iran
2 Internal Medicine Department, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
3 Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Nephrology Department, Mashhad University of Medical Sciences, Mashhad, IR Iran
5 Inflammation and Inflammatory Diseases Research Center, Medical School, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 2015, 8 (3); e59821
  • Published Online: March 21, 2015
  • Article Type: Research Article
  • Received: September 19, 2013
  • Revised: December 14, 2013
  • Accepted: July 6, 2014
  • DOI: 10.5812/jjm.14920

To Cite: Ahmadi Ghezeldasht S, Hassannia T, Rafatpanah H, Hekmat R, Valizadeh N, et al. Oncogenic Virus Infections in the General Population and End-stage Renal Disease Patients With Special Emphasis on Kaposi’s Sarcoma Associated Herpes Virus (KSHV) in Northeast of Iran, Jundishapur J Microbiol. 2015 ; 8(3):e59821. doi: 10.5812/jjm.14920.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-917[DOI][PubMed]
  • 2. Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Boamah I, Adu-Gyamfi C, et al. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study. BMC Infect Dis. 2008; 8: 33[DOI][PubMed]
  • 3. Saha A, Kaul R, Murakami M, Robertson ES. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention. Cancer Biol Ther. 2010; 10(10): 961-78[PubMed]
  • 4. Ahmadpoor P. Human herpesvirus-8 and Kaposi sarcoma after kidney transplantation: mechanisms of tumor genesis. Iran J Kidney Dis. 2009; 3(3): 121-6[PubMed]
  • 5. Allen UD. Human herpesvirus type 8 infections among solid organ transplant recipients. Pediatr Transplant. 2002; 6(3): 187-92[PubMed]
  • 6. Mendez JC, Paya CV. Kaposi's Sarcoma and Transplantation. Herpes. 2000; 7(1): 18-23[PubMed]
  • 7. Moore PS. The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). N Engl J Med. 2000; 343(19): 1411-3[DOI][PubMed]
  • 8. Plancoulaine S, Gessain A. [Epidemiological aspects of human herpesvirus 8 infection and of Kaposi's sarcoma]. Med Mal Infect. 2005; 35(5): 314-21[DOI][PubMed]
  • 9. Hjalgrim H, Melbye M, Pukkala E, Langmark F, Frisch M, Dictor M, et al. Epidemiology of Kaposi's sarcoma in the Nordic countries before the AIDS epidemic. Br J Cancer. 1996; 74(9): 1499-502[PubMed]
  • 10. Fickenscher H, Fleckenstein B. Herpesvirus saimiri. Philos Trans R Soc Lond B Biol Sci. 2001; 356(1408): 545-67[DOI][PubMed]
  • 11. Hanto DW. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med. 1995; 46: 381-94[DOI][PubMed]
  • 12. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12): 2212-9[DOI][PubMed]
  • 13. Ahmad B, Ali S, Ali I, Azam S, Bashir S. Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK). Virol J. 2012; 9: 18[DOI][PubMed]
  • 14. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001; 50: 1-43[PubMed]
  • 15. Green MAR, Preiksaitis J. Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant. 2004; 4(10)
  • 16. Ahmadi Ghezeldasht S, Shirdel A, Assarehzadegan MA, Hassannia T, Rahimi H, Miri R, et al. Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL). Iran J Basic Med Sci. 2013; 16(3): 179-95[PubMed]
  • 17. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011; 52(3): 172-6[DOI][PubMed]
  • 18. Azarpazhooh MR, Hasanpour K, Ghanbari M, Rezaee SA, Mashkani B, Hedayati-Moghaddam MR, et al. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis. AIDS Res Hum Retroviruses. 2012; 28(9): 1095-101[DOI][PubMed]
  • 19. Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ. Kaposi's sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol. 2006; 87: 1781-804[DOI][PubMed]
  • 20. Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011; 11(5): 346-50[PubMed]
  • 21. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009; 125(8): 1747-54[DOI][PubMed]
  • 22. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370(9581): 59-67[DOI][PubMed]
  • 23. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation. 1993; 56(1): 88-96[PubMed]
  • 24. Cohen P. Infectious Diseases. 2003;
  • 25. Cattani P, Capuano M, Graffeo R, Ricci R, Cerimele F, Cerimele D, et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol. 2001; 39(2): 506-8[DOI][PubMed]
  • 26. Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol. 2003; 57: 609-39[DOI][PubMed]
  • 27. Marcelin AG, Calvez V, Dussaix E. KSHV after an organ transplant: should we screen? Curr Top Microbiol Immunol. 2007; 312: 245-62[PubMed]
  • 28. Einollahi B, Noorbala MM, Lessan Pezeshki M, Khatami MR, Simforoosh N, Firoozan A, et al. Incidence of postrenal transplantation malignancies: a report of two centers in Tehran, Iran. Transplant Proc. 2001; 33(5): 2812[PubMed]
  • 29. Qunibi W, Al-Furayh O, Almeshari K, Lin SF, Sun R, Heston L, et al. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation. 1998; 65(4): 583-5[PubMed]
  • 30. Jalilvand S, Shoja Z, Mokhtari-Azad T, Nategh R, Gharehbaghian A. Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran. Infect Agent Cancer. 2011; 6: 5[DOI][PubMed]
  • 31. Frances C, Mouquet C, Calvez V. Human herpesvirus 8 and renal transplantation. N Engl J Med. 1999; 340(13): 1045[DOI][PubMed]
  • 32. Bergallo M, Costa C, Margio S, Sidoti F, Re D, Segoloni GP, et al. Human herpes virus 8 infection in kidney transplant patients from an area of northwestern Italy (Piemonte region). Nephrol Dial Transplant. 2007; 22(6): 1757-61[DOI][PubMed]
  • 33. Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 1997; 276(5320): 1851-4[PubMed]
  • 34. Wolf R, Brenner S, Ruocco V, Filioli FG. Isotopic response. Int J Dermatol. 1995; 34(5): 341-8[PubMed]
  • 35. Rosen HR. Hepatitis B and C in the liver transplant recipient: current understanding and treatment. Liver Transpl. 2001; 7(11 Suppl 1)-98[DOI][PubMed]
  • 36. Naghibi O, Nazemian F, Naghibi M, Ali Javidi DB. Prognosis of HTLV-1 positive renal transplant recipients in Iran. Saudi J Kidney Dis Transpl. 2011; 22(4): 670-4[PubMed]
  • 37. Brown RS. Hepatitis C and liver transplantation. Nature. 2005; 436(7053): 973-8[DOI][PubMed]
  • 38. Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol. 1999; 94(1): 159-63[DOI][PubMed]
  • 39. Fabrizi F, Lunghi G, Poordad FF, Martin P. Management of hepatitis B after renal transplantation: an update. J Nephrol. 2002; 15(2): 113-22[PubMed]
  • 40. Nakamura N, Tamaru S, Ohshima K, Tanaka M, Arakaki Y, Miyauchi T. Prognosis of HTLV-I-positive renal transplant recipients. Transplant Proc. 2005; 37(4): 1779-82[DOI][PubMed]
  • 41. Khameneh ZR, Sepehrvand N, Masudi S, Taghizade-Afshari A. Seroprevalence of HTLV-1 among kidney graft recipients: a single-center study. Exp Clin Transplant. 2010; 8(2): 146-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments